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Abstract
In a mouse model of respiratory tract infection by Bordetella pertussis, bacteria multiply in the airways over the first week
and are then cleared over the next 3–4 weeks by the host immune response. Pertussis toxin (PT), a virulence factor secreted
exclusively by B. pertussis, promotes bacterial growth in the airways by suppression and modulation of host immune
responses. By comparison of wild type and PT-deficient strains, we examined the role of PT in modulating airway cytokine
and chemokine responses affecting neutrophil recruitment during B. pertussis infection in mice. We found that, despite early
inhibition of neutrophil recruitment by PT, high numbers of neutrophils were recruited to the airways by 4 days post-
infection with the wild type strain, but not with the PT-deficient strain, and that this correlated with upregulation of
neutrophil-attracting chemokine gene expression. In addition, there was similar upregulation of genes expressing the
cytokines IL-17A (IL-17), TNF-a and IFN-c, indicating a mixed Th1/Th17 response. Expression of IL-6, a cytokine involved in
Th17 induction, was upregulated earlier than the IL-17 response. We showed that PT, rather than bacterial numbers, was
important for induction of these responses. Flow cytometric analysis revealed that the IL-17-producing cells were
macrophages and neutrophils as well as T cells, and were present predominantly in the airways rather than the lung tissue.
Antibody neutralization of IL-17 significantly reduced chemokine gene expression and neutrophil recruitment to the
airways, but only modestly increased peak bacterial loads. These data indicate that PT stimulates inflammatory responses by
induction of Th1- and Th17-associated cytokines, including IL-17, during B. pertussis infection in mice, but a role for IL-17 in
protection against the infection remains to be established.
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Introduction
Bordetella pertussis is a Gram-negative bacterial pathogen that
infects the human respiratory tract and causes an acute disease
known as pertussis or whooping cough. The bacteria adhere to
ciliated cells and proliferate within the upper and lower respiratory
tract, and do not disseminate to other tissues [1]. A mouse model
of respiratory tract infection by this pathogen has been widely used
to study the roles of various virulence factors, the associated
pathology, and the immune responses elicited by the infection.
Although symptomatic disease (cough) and transmission are not
observed in the mouse model, several characteristics of the human
disease are present, such as bacterial multiplication and clearance,
limitation of the infection to the respiratory tract, and increased
severity of infection in infant mice [2,3]. In addition, systemic
effects of the disease observed in humans, such as leukocytosis and
hypoglycemia, can be detected in infected mice [3]. These
characteristics, as well as the availability of inbred mice and
genetically altered immunodeficient strains, make the mouse
model useful for the study of host immune responses to B. pertussis
infection.
B. pertussis produces several virulence-associated factors that
contribute to the ability of this pathogen to infect the respiratory
tract and cause disease. Among these virulence factors are two
secreted toxins, pertussis toxin (PT) and adenylate cyclase toxin
(ACT), both of which have suppressive and modulatory effects on
the immune response [1]. PT, which is produced exclusively by
B. pertussis, is a six-subunit exotoxin of AB5 configuration that
ADP-ribosylates the a subunit of Gi proteins in mammalian cells,
thereby inhibiting many cell signaling events through G protein-
coupled receptors. By comparing wild type and PT-deficient
B. pertussis strains in the mouse model, our group has recently
shown that PT contributes significantly to bacterial growth in the
respiratory tract by effects on host cells of the airways, including
inhibitory effects on the protective role of resident airway
macrophages [4,5,6]. PT also inhibits early neutrophil influx to
the airways after infection by suppressing the early production of
the neutrophil-attracting chemokines KC, LIX and MIP-2 by
airway macrophages and epithelial cells [7].However, this latter
property may not contribute significantly to bacterial growth, at
least in naı ¨ve mice, since neutrophil depletion did not increase
bacterial loads, possibly because of the inhibitory activities of PT
and ACT on neutrophils [8].
Several studies have shown that PT and ACT also modulate
cytokine responses produced by immune cells and during infection
in the mouse model. ACT can upregulate major histocompatibility
complex class II and costimulatory molecules on dendritic cells,
inducing a semi-mature state that induces IL-10 production and
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ever, ACT may also have proinflammatory properties since it can
induce cyclooxygenase-2 (COX-2) and interleukin 6 (IL-6)
production by macrophages in vitro [12]. PT can inhibit
production of tumor necrosis factor-alpha (TNF-a) and IL-6, as
well as various chemokines, by mouse macrophages in response to
LPS [8,13,14]. However, PT can also synergize with LPS to
induce proinflammatory cytokine production by dendritic cells
[15]. Therefore the modulatory activities of these toxins on
cytokine production are complex and may depend on several
variables, including host cell type and other bacterial factors. How
these toxins modulate cytokine immune responses during infection
by B. pertussis is even less clear.
Several recent studies on immunomodulation by B. pertussis have
shown that the host immune response may be skewed towards
expansion of a subset of T lymphocytes termed Th17 cells, which
produce the cytokine IL-17A (hereafter referred to as IL-17) [16],
despite earlier studies having indicated that B. pertussis infection
promotes a Th1 immune response (based largely on IFN-c
production) [2,17]. Incubation of human dendritic cells with B.
pertussis induced ACT-dependent expression of IL-23, a cytokine
important for the expansion and maintenance of Th17 cells, but
not of the Th1-inducing cytokine IL-12 [18,19]. B. pertussis
infection or pertussis vaccination of mice also induced an IL-17
response that was dependent on TLR4 signaling and IL-1, and
that contributed to protection against B. pertussis challenge [16,20].
Th17 cells are considered important for the host immune response
against extracellular pathogens in the airways [21,22], but are also
associated with chronic inflammation and autoimmunity [23,24].
IL-17 induces the production of inflammatory chemokines and
cytokines and contributes to neutrophil recruitment and activation
of innate immune cells [25,26]. IL-17 is mainly produced by T
cells but it can also be produced by neutrophils [22,27] and NK
cells [28]. Whether IL-17 and the Th17-polarized immune
response contribute to protection against B. pertussis infection is
still unclear, although this response has been shown to play a role
in protection against another Gram-negative bacterial respiratory
pathogen, Klebsiella pneumoniae [29].
Recently we have shown that PT inhibits the recruitment of
neutrophils to B. pertussis-infected airways in mice over the first
2 days post-inoculation, but that this inhibition is subsequently
overcome, with high numbers of neutrophils present in the airways
by day 4 [5,7,8]. In this study we examined a more extended time
course of neutrophil recruitment to the airways as well as cytokine
and chemokine induction after B. pertussis infection, and tested the
hypothesis that the later neutrophil recruitment is due to PT-
dependent induction of a Th17 response and IL-17 activity.
Results
Effect of PT on kinetics of neutrophil recruitment to the
airways in response to B. pertussis infection
Previously, by comparison of WT and DPT strains of B. pertussis
we found that PT inhibits the recruitment of neutrophils to B.
pertussis-infected airways in mice over the first 1–2 days post-
inoculation, but that this inhibition is subsequently overcome, with
high numbers of neutrophils present in the airways of WT-infected
mice by day 4 [5,30]. To determine the extended kinetics of
neutrophil recruitment to the airways in response to WT and DPT
infection, we inoculated mice with 5610
5 CFU of either strain
(a dose at which DPT has a significant infection defect) and
performed bronchoalveolar lavage (BAL) on groups of mice at
several time points post-inoculation to determine the number of
neutrophils present in the airways, as well as determining bacterial
loads in the respiratory tract. As seen previously, early (day 1)
recruitment of neutrophils to the airways was significantly lower
(p,0.002) in response to WT than to DPT (Fig. 1A), but by day 2
post-inoculation, the difference in neutrophil recruitment in
response to the two strains was eliminated (p=0.64). On days 4,
7, and 14 post-inoculation, we saw high numbers of airway
neutrophils in response to WT infection but not to DPT infection,
with the numbers still rising at day 14 (Fig. 1A). This second wave
of neutrophil recruitment in response to the WT strain occurred
during the peak phase of infection, and lasted at least until day 14
post-inoculation when bacterial numbers were declining (Fig. 1B).
As we have seen previously, bacterial loads of the WT strain were
at least 10-fold higher than those of DPT at these time points
(Fig. 1B), and so it is possible that high levels of bacterial factors,
including LPS, can overcome the inhibitory effect of PT and
stimulate the high level neutrophil recruitment in response to WT
at the peak of infection. However, another possibility is that PT
has a direct effect on this stimulation by modulating immune
responses, thereby inducing a strong neutrophil recruitment in
response to infection.
Figure 1. Kinetics of neutrophil recruitment during B. pertussis
WT and DPT infection. (A) Numbers of neutrophils in the airways and
(B) bacterial loads in the respiratory tract of mice at the indicated times
post-infection with 5610
5 CFU of WT (closed bars) or DPT (open bars)
strains. n=4 mice/treatment group. The data represent 1 of 3 separate
experiments with similar results. * Significantly different from WT
(P,0.05).
doi:10.1371/journal.pone.0007079.g001
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peak of infection
To determine if the second wave of neutrophil recruitment in
response to WT infection was due to induction of neutrophil-
attracting chemokines, we analyzed the gene expression of KC,
LIX and MIP-2 (ELR+ CXC chemokines that are important in
neutrophil recruitment in mice and are functional homologues of
IL-8 in humans) in lung samples on days 1, 2, 4 and 7 post-
inoculation with 5610
5 CFU of either WT or DPT strains.
Previously we found that expression of these chemokine genes
was significantly increased above background at 6 h post-
inoculation, that this early increase was significantly inhibited
by PT, and that gene expression levels returned to background
by 12 h post-inoculation [7]. This resulted in a higher level of
neutrophil influx to the DPT strain than to the WT strain at day
1 post-inoculation (Fig. 1A and ref. 1). Though this early
response is inhibited by PT, in contrast we observed strong
induction of expression of all three chemokine genes in response
to WT infection at later time points (Fig. 2). By day 2 post-
inoculation, expression of KC was significantly higher in
response to infection with WT than with DPT and at day 4,
KC gene expression in response to WT infection was induced
28-fold above the control (mock-infected mice) and 8-fold above
the level in response to DPT infection (Fig. 2A). The level of KC
gene expression in response to WT was somewhat reduced by
day 7 post-inoculation, although still significantly higher than the
expression in response to DPT infection (Fig. 2A). A very similar
expression profile was observed for MIP-2 gene expression in
response to WT and DPT infection (Fig. 2B). LIX gene
expression was also strongly induced in response to WT infection
(Fig. 2C). At day 4 post-inoculation, there was a 20-fold increase
in response to WT (above controls) and by day 7 post-
inoculation, LIX was expressed 80-fold higher than controls,
and at each of these time points LIX gene expression was
significantly higher (4-6-fold) in response to WT than to DPT
infection (Fig. 2C). We also determined the level of chemokine
gene expression in mice infected with the B. pertussis PT* strain
(that produces an enzymatically inactive form of PT) at days 2, 4
and 7 post-inoculation. The expression of chemokine genes in
response to the PT* strain followed a very similar pattern to that
of DPT (Fig. 2A–C), indicating that any differences in the
responses to WT and DPT are due to the enzymatic activity of
PT. Bacterial loads of the PT* strain were not significantly
different from those of the DPT strain at the corresponding time
points (data not shown), as we have previously observed [5].
Expression of lung cytokines in response to WT and DPT
infection
To investigate how the increase in chemokines and neutrophil
recruitment in response to the WT strain at the peak of infection
might be induced, we analyzed the expression of several other pro-
inflammatory cytokine genes in the lungs in response to WT and
DPT infection. The production of IL-17 is associated with
induction of neutrophil-recruiting chemokines and subsequent
neutrophil recruitment [24], suggesting a possible role for IL-17 in
recruitment of neutrophils in response to B. pertussis at the peak of
infection. Lung samples from mice infected with WT or DPT were
analyzed for the expression of IL-17 to determine if there was a
difference in the induction of this inflammatory cytokine in
response to the two strains. IL-17 gene expression was not induced
above control levels in response to WT or DPT over the first two
days post-infection (Fig. 3A). By day 4 after WT infection, IL-17
gene expression was increased 20-fold above that of control and
DPT groups, with a peak of approximately 80-fold induction on
day 7 post-infection. While declining after day 7, IL-17 gene
expression remained 15-25-fold higher in response to WT
Figure 2. Kinetics of chemokine gene expression during B.
pertussis WT, DPT and PT* infection. Fold increases in gene
expression (relative to mock-infected mice) of the chemokines (A) KC,
(B) MIP-2, and (C) LIX in lungs of mice at the indicated times post-
infection with 5610
5 CFU of WT (black bars), DPT (open bars) or PT*
(grey bars) strains. n=4 mice/treatment group. The data represent 1 of
2 separate experiments with similar results. * Significantly different from
WT (P,0.05).
doi:10.1371/journal.pone.0007079.g002
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after inoculation (Fig. 3A), despite low bacterial loads at these time
points. At this dose (5610
5 CFU), we saw no significant increase in
IL-17 gene expression in response to DPT over the control group.
IL-17 protein expression in lungs was also significantly higher in
WT-infected mice than in DPT-infected mice at the peak of
infection (Fig. 3B). These data demonstrate that the kinetics of IL-
17 expression closely matches that of chemokine upregulation and
neutrophil recruitment to the airways, suggesting an association
between these events, and that WT infection stimulates a
prolonged upregulation of IL-17 gene expression.
TNF-a is another pro-inflammatory cytokine associated with
Th17 responses, and IL-17 can further increase the production of
TNF-a [23]. Low levels of TNF-a gene expression were detected
in response to WT and DPT through day 2 post-infection, but at
day 4 we observed a 30-fold increase in TNF-a gene expression in
response to WT infection (Fig. 3G). TNF-a gene expression
responses to DPT infection remained near background levels
throughout (Fig. 3G). By days 14 and 20, TNF-a gene expression
in response to WT infection was reduced to 5-7-fold above those of
control and DPT groups, indicating an extended response to WT
infection similar to that seen for IL-17.
IL-6 is a proinflammatory cytokine produced by several cell
types and implicated in the induction of Th17 responses [24]. By
24 h post-infection, IL-6 gene expression in response to WT and
DPT was 6- and 14-fold higher than that of the control group,
respectively, suggesting an inhibitory role for PT on IL-6 gene
expression early after infection (Fig. 3C). Subsequently, however,
there was a 15-25-fold induction of IL-6 gene expression in
response to WT infection, while the response to DPT was reduced
to near background levels, indicating that PT may be responsible
for IL-6 induction subsequent to the early inhibition. IL-6 protein
levels reflected the differences in gene expression in response to
infection with WT and DPT (Fig. 3D). The induction of IL-6
expression on day 2 after WT infection precedes the induction of
IL-17 gene expression (not observed until day 4 – Fig. 3A),
consistent with a possible role for IL-6 in inducing the IL-17
response.
IFN-c is a cytokine typically associated with Th1 responses, but
a mixed Th1/Th17 response to B. pertussis infection has previously
Figure 3. Kinetics of cytokine expression during B. pertussis WT and DPT infection. Fold increases in gene expression (relative to mock-
infected mice) of the cytokines (A) IL-17, (C) IL-6, (E) IFN-c, (G) TNF-a, and (H) IL-10, and corresponding protein levels of (B) IL-17, (D) IL-6 and (F) IFN-c
in lungs of mice at the indicated times post-infection with 5610
5 CFU of WT (black bars) or DPT (open bars) strains. n=4 mice/treatment group. The
data represent 1 of 2 separate experiments with similar results. *Significantly different from WT (P,0.05).
doi:10.1371/journal.pone.0007079.g003
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gene expression or protein levels were observed in response to WT
or DPT through day 2 post-infection (Fig. 3E,F). By day 4,
however, there was a 70-fold increase in IFN-c gene expression in
response to WT infection, with a peak on day 7 post-infection (90-
fold above control), whereas IFN-c gene expression in response to
DPT infection remained near control levels (Fig. 3E). IFN-c
protein levels were also significantly higher in response to infection
with WT than with DPT at these time points (Fig. 3F). Unlike
IL-17 and TNF-a gene expression, the IFN-c response returned to
control levels by day 14 post-infection (Fig. 3E), suggesting that a
Th1 response is induced only at the peak of infection and is more
transient than the Th17 response. These data indicate that B.
pertussis infection induces a Th1/Th17 immune response in a
mouse model. However, while the Th1 response appears to be
relatively short-lived and IFN-c is produced only during the peak
of infection, the Th17 response is more prolonged and Th17
cytokines are elevated even while the bacteria are being cleared.
IL-10 is generally considered to be a Th2-associated cytokine
and has immunosuppressive properties [31]. No significant
increases in IL-10 gene expression were observed in response to
WT or DPT through day 2 post-infection (Fig. 3H). By day 4,
however, there was a 9-fold increase in IL-10 gene expression in
response to WT infection, whereas IL-10 gene expression in
response to DPT infection remained near control levels (Fig. 3H).
At day 7 post-infection there was a 4-fold increase in IL-10 gene
expression in response to both strains (Fig. 3H).
The role of PT in induction of proinflammatory responses
during B. pertussis infection
As shown above, inoculation of mice with 5610
5 CFU of WT B.
pertussis induces a strong Th1/Th17 response at the peak of
infection, whereas infection with the same dose of DPT induces
only low levels of inflammatory cytokines. Since the WT strain
grows to significantly higher numbers in the airways than the DPT
strain after day 2 post-infection (Fig. 1B), the increased
inflammatory response to infection by the WT strain may be
caused either by high bacterial loads or through a more direct
induction by PT (or possibly both). In an attempt to discriminate
between these two possibilities, we equalized bacterial loads of the
2 strains at the peak of infection by inoculating groups of mice with
10-fold higher levels of DPT than WT, which resulted in
approximately equal bacterial loads in the airways on days 4
and 7 post-infection (Fig. 4A,B). We inoculated groups of mice
with a low dose of WT (5610
4 CFU) versus our normal dose of
DPT (5610
5 CFU) (Fig. 4A), or with the normal dose of WT
(5610
5 CFU) versus a high dose of DPT (5610
6 CFU) (Fig. 4B), to
examine the role of PT in induction of pro-inflammatory responses
at different levels of infection. With the low dose of WT versus the
regular dose of DPT, IL-17 gene expression showed a 3-4-fold
induction in response to WT, but not to DPT, on days 4 and 7
after inoculation (Fig. 4C). Inoculation with the regular dose of
WT versus a high dose of DPT resulted in strong induction of
IL-17 gene expression in response to WT (10-fold on day 4 and
40-fold on day 7 - Fig. 4D), similar to that seen previously (Fig. 3A).
Once again IL-17 gene expression was significantly lower in
response to DPT infection (5-fold on day 4 and 15-fold on day 7 -
Fig. 4D). Collectively these data indicate that PT makes a major
contribution to induction of the IL-17 response during B. pertussis
infection independently of bacterial load, but that induction of this
response is not absolutely dependent upon PT, since infection with
the higher dose of DPT resulted in IL-17 gene expression
significantly above background.
To determine if the Th1 response to WT infection is also
induced by PT, we examined IFN-c gene expression, using the
samples from mice infected with 5610
5 CFU of WT versus 5610
6
CFU of DPT. In response to WT infection, there was a 20-fold
increase above controls in IFN-c gene expression on day 4 and a
60-fold increase by day 7, significantly higher than that in response
to DPT infection (5-10-fold increase above control) (Fig. 4E),
indicating that PT induces Th1 as well as Th17 responses during
B. pertussis infection.
Flow cytometry analysis of IL-17-producing cells in mice
infected with B. pertussis WT and DPT
To confirm the difference in IL-17 production in WT- and
DPT-infected mice and to identify the cells producing IL-17 at the
peak of infection, we performed flow cytometry analysis of cells
infiltrating the lungs and airways in response to these infections.
Mice were infected with 5610
5 CFU of either strain, and lung and
BAL cells from groups of mice (n=3) were analyzed 7 days post-
infection. CD3
+ T cells made up 2.5% of BAL cells in WT-
infected mice and 25% of these T cells were IL-17
+, whereas less
Figure 4. Effect of equalizing bacterial loads of WT and DPT on
IL-17 expression. (A, B) Bacterial loads in the respiratory tract of mice
on the indicated days post-infection with (A) 5610
4 CFU of WT (black
bars) versus 5610
5 CFU of DPT (open bars), or (B) 5610
5 CFU of WT
versus 5610
6 CFU of DPT (compare to difference in bacterial loads
when inoculum doses are equal in Fig. 1). (C–E) Fold increases in gene
expression (relative to mock-infected mice) of the cytokines IL-17 (C, D)
or IFN-c (E) in lungs of mice on the indicated days post-infection with
the lower doses (C) or higher doses (D, E) of WT (black bars) or DPT
(open bars) strains. n=4 mice/treatment group. *Significantly different
from WT (P,0.05).
doi:10.1371/journal.pone.0007079.g004
PT Stimulates IL-17 Response
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7079than 1% of BAL cells in DPT-infected mice were CD3
+ T cells and
only 2% of these were IL-17
+ (Fig. 5A, B, D, E). In addition, the
mean fluorescence intensity (MFI) of IL17 staining on CD3
+ T
cells among BAL cells from WT-infected mice was 5-fold higher
than that from DPT-infected mice (Fig. 5C–E). Surprisingly, there
was no significant presence of IL-17
+ T cells in the lung tissue of
WT-infected mice, and all of these cells appeared to be present in
the airways (BAL cells - Fig. 5F, G). In addition, T cells were not
the only producers of IL-17. Neutrophils (defined as Gr1
hi
CD11b
+) made up a greater percentage of BAL cells in WT-
infected mice than in DPT-infected mice (Fig. 6A) consistent with
our earlier data, and 33% of these neutrophils from WT-infected
mice were IL-17
+, whereas there was a very small number of
weakly-staining IL-17
+ neutrophils from DPT-infected mice
(Fig. 6B–E), indicating that neutrophils are also significant IL-17
producers in this infection. Furthermore, 12% of airway




positive for IL-17 in WT-infected mice, but less than 1% in DPT-
infected mice (Fig. 6G–J). Again there were very few IL-17
+
neutrophils or macrophages in the lung tissue of these mice (data
not shown). Collectively these data confirm that the IL-17
response is significantly higher in WT-infected mice than in
DPT-infected mice, supporting a role for PT in this induction, and
demonstrate that multiple cell types (including T cells, neutrophils
and macrophages) in the airways produce IL-17 at the peak of this
infection.
Neutrophil recruitment and chemokine gene expression
after administration of a-IL-17 antibody
Th17 responses and the production of IL-17 have been
associated with the induction of chemokine production and strong
neutrophil recruitment [24]. To examine if the increase in
chemokine gene expression and neutrophil recruitment in
response to the WT strain during the peak phase of infection is
induced by the production of IL-17, we administered 100 mgo f
a-IL-17 monoclonal antibody (or rat IgG to control mice)
intranasally to mice on day 3 post-inoculation with 5610
5 CFU
of the WT strain (a time point just prior to the observed increase in
IL-17 expression – Fig. 3A). Groups of mice were euthanized on
day 4 post-inoculation and KC gene expression, neutrophil
recruitment and bacterial loads in the lungs were examined. KC
gene expression in response to WT infection was induced
approximately 30-fold above background levels (Fig. 7A),
comparable to levels we observed previously in response to WT
on day 4 post-infection (Fig. 2A). Treatment of mice with a-IL-17
monoclonal antibody significantly reduced KC expression in
response to infection (Fig. 7A) and this corresponded to a
significant reduction in neutrophil recruitment to the airways
(Fig. 7B), indicating that IL-17 plays a role in inducing
chemokine expression and subsequent neutrophil recruitment
in response to WT B. pertussis at the peak of infection. Bacterial
loads in these mice treated with a-IL-17 were 2-fold higher than
those in control antibody-treated mice (Fig. 7C), but this
difference was not statistically significant. To determine whether
continued neutralization of IL-17 throughout the peak of
infection would significantly increase bacterial loads, mice
infected with 5610
5 CFU WT were treated with 100 mgo f
a-IL-17 monoclonal antibody (or rat IgG control antibody) on
days 3, 5 and 7 post-infection and bacterial loads were assessed
on day 8. Once again there was a modest (2.5-fold) increase in
bacterial loads in a-IL-17-treated mice than in control mice
(Fig. 7D), though this difference was statistically significant
(p=0.02). To determine whether continued neutralization of
IL-17 after the peak of infection during clearance would
significantly increase bacterial loads, mice infected with 5610
5
CFU WT were treated with 100 mgo fa-IL-17 monoclonal
Figure 5. Flow cytometry analysis of airway T cells at the peak of WT or DPT infection. (A) Percentage of T cells (defined as CD3
+) in the
BAL fluid from mice infected with 5610
5 CFU of B. pertussis WT (black bars) or DPT (grey bars). (B, C) Percentage of T cells that stained positive for IL-
17 (B) and mean fluorescence intensity (MFI) of IL-17 staining in those cells (C) in the BAL fluid of mice infected with 5610
5 CFU of B. pertussis WT
(black bars) or DPT (grey bars). (D, E) Representative contour plots of IL-17 staining in T cells in the BAL fluid of mice infected with either WT or DPT.
Number in box denotes the percentage of IL-17
+ T cells. SSC – side scatter. (F, G) Representative histograms of IL-17 staining of T cells in the BAL fluid
(F) or lung tissue (G) of mice infected with either WT (open plot) or DPT (shaded plot).
doi:10.1371/journal.pone.0007079.g005
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18 post-infection and bacterial loads were assessed on days 14
and 21. As shownin Fig. 7E, there was no significant difference in
bacterial loads between treated and control mice at these time
points. a-IL-17 antibody-treated mice had reduced neutrophil
numbers in the airways compared to control mice (data not
shown), demonstrating the efficacy of the antibody treatment.
Therefore IL-17 may contribute to protection against B. pertussis
infection in this model, although apparently not in a dominant
manner, and does not seem to contribute to clearance of the
infection.
Discussion
Previously we reported that PT inhibits early (day 1–2)
neutrophil influx to the airways in response to B. pertussis infection
in Balb/c mice [5,7,30], through a mechanism involving inhibition
of neutrophil-attracting chemokine gene expression [7]. In this
report we showed that subsequent to this early inhibitory phase, a
second wave of neutrophil recruitment in response to WT B.
pertussis infection occurs, starting before the peak of infection (day
3–4) and remaining until at least 14 days post-infection, when only
low bacterial loads are seen in the airways. This second wave of
neutrophil recruitment is stimulated through PT activity by
upregulation of cytokines including IL-17, which then upregulates
neutrophil-attracting chemokine gene expression. When compar-
ing the infections with the WT and DPT strains of B. pertussis after
inoculation with equivalent doses, there are 2 variables to consider
(at least beyond day 1 post-inoculation): (i) the production of PT by
the WT strain, and (ii) the higher bacterial load achieved by the
WT strain. By inoculating mice with higher doses of DPT than
WT, we demonstrated that PT, rather than bacterial load, was the
more important factor in stimulating these inflammatory responses
at the peak of B. pertussis infection.
Recent evidence suggests that production of chemokines and
subsequent neutrophil recruitment to the airways in response to
infection can be induced by a Th17 response, which is associated
with the release of IL-17 as well as other pro-inflammatory
cytokines. IL-17, in turn, results in the production of chemokines
by resident cells of the lung [22,27,32], leading to a strong
neutrophil recruitment to the airways. The Th17 responses are
driven, in part, by the production of IL-6 [24] and are associated
with increased release of TNF-a [33]. In our studies, there was
significantly greater induction of IL-6 gene expression in response
to DPT than WT on day 1 post-infection. However, this induction
of IL-6 was short-lived and not associated with the production of
IL-17 or TNF-a. In response to WT infection, however, there was
a strong induction of IL-6 by day 2 post-infection, which preceded
the induction of IL-17 and TNF-a, consistent with the established
role of IL-6 in Th17 induction [24]. In support of this effect of PT,
a recent report demonstrated that PT stimulated the generation of
Th17 cells in co-cultured naı ¨ve T cells and dendritic cells in an
IL-6-dependent manner [34]. Which target cells and signaling
pathways PT might affect in vivo to bring about these influences
on immune responses remains to be elucidated.
Several reports have shown that infection with B. pertussis in both
humans and mice induces a Th1 response [18,35,36]. However,
there are reports indicating that the production of IFN-c inhibits
the induction of IL-17 responses [24,37] as well as evidence
suggesting that IL-17 can inhibit Th1 responses [37]. Nevertheless,
a Th1/Th17 response with the production of both Th1 and Th17
cytokines has been described recently [16,38] and a report by
Figure 6. Flow cytometry analysis of airway neutrophils and macrophages at peak WT or DPT infection. (A) Percentage of neutrophils
(defined as Gr1
hi CD11b
+) in the BAL fluid from mice infected with 5610
5 CFU of B. pertussis WT (black bars) or DPT (grey bars). (B, C) Percentage of
neutrophils that stained positive for IL-17 (B) and mean fluorescence intensity (MFI) of IL-17 staining in those cells (C) in the BAL fluid of mice infected
with 5610
5 CFU of B. pertussis WT (black bars) or DPT (grey bars). (D, E) Representative contour plots of IL-17 versus CD11b staining in neutrophils in
the BAL fluid of mice infected with either WT (D) or DPT (E). Number in box denotes the percentage of IL-17
+ neutrophils. (F) Percentage of
macrophages (defined as CD11b
2 CD11c
+ Gr1
lo) in the BAL fluid from mice infected with 5610
5 CFU of B. pertussis WT (black bars) or DPT (grey bars).
(G, H) Percentage of macrophages that stained positive for IL-17 (G) and MFI of IL-17 staining in those cells (H) in the BAL fluid of mice infected with
5610
5 CFU of B. pertussis WT (black bars) or DPT (grey bars). (I, J) Representative contour plots of IL-17 versus CD11c staining in macrophages in the
BAL fluid of mice infected with either WT (I) or DPT (J). Number in box denotes the percentage of IL-17
+ macrophages.
doi:10.1371/journal.pone.0007079.g006
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pertussis vaccine leads to the induction of a Th17/Th1 response
[16]. In our studies, IFN-c gene expression was induced strongly in
response to the WT strain at the peak of infection, while the
induction of IFN-c in response to DPT was relatively low,
consistent with the notion that B. pertussis infection induces a Th1/
Th17 response that is promoted by PT. However, while the
induction of the Th17 response was long-lived and gene expression
remained up-regulated (several fold) even while the infection was
being cleared, the Th1 response was only induced during the peak
of infection (days 4 and 7) and gene expression of IFN-c was
reduced to that of control levels by day 14 post-infection. We also
detected an increase in IL-10 gene expression near the peak of
infection with WT, but not DPT, indicating induction of a
complex mixture of T cell subtypes during this infection. Overall
our data are consistent with the emerging finding that B. pertussis
infection modulates the immune response towards a Th1/Th17
response.
Our flow cytometry analysis revealed the presence of significant
numbers of IL-17
+ cells in WT-infected mice but not in DPT-
infected mice, consistent with the gene expression data. We were
surprised to find that the IL-17
+ cells were predominantly in the
airways (BAL) rather than the lung tissue. However, this may be a
technical artifact due to the relatively lengthy procedure to isolate
lung cells during which cytokines may have been released
(although in one attempt at in vitro restimulation of lung cells in
the presence of Brefeldin A we did not detect any IL-17
+ cells –
data not shown). We were also surprised to find that the IL-17
+
cells included neutrophils and macrophages as well as T cells.
Which of these cells actually secrete the cytokine during infection
remains to be determined however, since intracellular staining was
used to detect cytokine expression in our analysis.
Several recent studies suggest that toxins released by Bordetella
species may induce a Th17 response. Adenylate cyclase toxin
(ACT) and the type III secretion system may contribute to
induction of a Th17 response to Bordetella infection [39]. LPS
signaling through TLR4 also contributes to Th17 responses in
mixed cell culture [40] or after B. pertussis infection and pertussis
vaccination [16,20]. We have also found a role for ACT in
promoting a Th17 response to B. pertussis, and our data suggest
that PT and ACT may have a synergistic effect on the induction of
Th1 and Th17 cytokines (Andreasen and Carbonetti, manuscript
in preparation). Whether the Th17 response plays a role in
protection against primary B. pertussis infection is still unclear.
Higgins et al. showed that a possible role for IL-17 in protective
immunity to B. pertussis was enhancing bacterial killing by
macrophages [16]. In our studies, intranasal administration of
a-IL-17 antibodies only modestly enhanced peak bacterial growth
in the airways and did not delay clearance of the infection,
although this treatment did inhibit KC gene expression and
neutrophil recruitment to the airways in response to B. pertussis
infection. We have recently shown that neutrophils are not
protective against primary B. pertussis infection [8] suggesting that
if IL-17 is protective against this infection it must act through
another mechanism, such as enhancing macrophage activity.
Alternatively, other Th17-associated cytokines, such as IL-22 [21],
may be important or may synergize with IL-17 to control this
infection. Clearance of primary B. pertussis infection involves T
cells, since T cell-deficient mice fail to clear the infection [41], but
the relative contribution of Th1 and Th17 cells and the
mechanisms utilized are still unknown.
Th17 responses have been implicated in the pathogenesis of
several chronic immune-mediated pathologies, such as asthma,
multiple sclerosis, arthritis and colitis [24], so it is tempting to
speculate that this response may also contribute to the pathology of
pertussis [1], especially the prolonged cough associated with this
disease. We have detected significant IL-17 gene expression and
high numbers of neutrophils in the lungs of mice 21 days after B.
pertussis infection (data not shown - we have not yet assayed later
time points), and neutrophilia in the airways has been associated
with non-specific symptoms such as cough and bronchial
hyperactivity and hypersecretion [22]. Therefore, it is plausible
that induction of a Th17 response and subsequent recruitment of
Figure 7. Effect of a–IL-17 antibody treatment on B. pertussis
WT infection. (A–C) Fold increases in gene expression (relative to
mock-infected mice) of KC (A), numbers of airway neutrophils (B), and
bacterial loads in the respiratory tract (C) in control or a–IL-17 antibody-
treated mice on day 4 post-infection with 5610
5 CFU of WT B. pertussis.
Mice were treated with antibody intranasally on day 3 post-infection.
(D) Bacterial loads in the respiratory tract of control or a–IL-17 antibody-
treated mice on day 8 post-infection with 5610
5 CFU of WT B. pertussis.
Mice were treated with antibody intranasally on days 3, 5 and 7 post-
infection. (E) Bacterial loads in the respiratory tract of control or a–IL-17
antibody-treated mice on days 14 and 21 post-infection with 5610
5
CFU of WT B. pertussis. Mice were treated with antibody intranasally on
days 3, 6, 9, 12, 15 and 18 post-infection. *Significantly different from
control mice (P,0.05).
doi:10.1371/journal.pone.0007079.g007
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prolonged paroxysmal cough associated with B. pertussis infection
in humans. Until we have a cough model for this infection we will
not be able to test this hypothesis.
Materials and Methods
Bacterial Strains
The B. pertussis strains used for this study were streptomycin- and
nalidixic acid-resistant derivatives of Tohama I and were produced
as previously described [5]. The PT-deficient mutant strain (DPT)
contains an in-frame deletion of PT genes and the wild-type (WT)
strain is the parental strain that produces native PT. The PT* strain
of B. pertussis produces PT with 2 amino acid substitutions in the S1
subunit, rendering the toxin enzymatically inactive and thereby
unable to ADP-ribosylate target Gi proteins [42]. B. pertussis strains
were grown on Bordet-Gengou (BG) agar plates containing 10%
defibrinated sheep blood and 400 mg/ml of streptomycin.
Mouse Infection
All mouse procedures were performed in accordance with the
Public Health Service Policy on the Humane Care and Use of
Laboratory Animals, and with a protocol approved by the
University of Maryland, Baltimore Institutional Animal Care and
Use Committee. Six-week-old female BALB/c mice (Charles River
Laboratories) were used in our studies. Inocula were prepared and
mice were inoculated intranasally as previously described [7]. Mice
were euthanized by carbon dioxide inhalation at specified time
points and the lungs and trachea were removed and homogenized
in 2 ml of sterile PBS. Appropriate dilutions were plated on BG
blood agar plates with streptomycin and counted after 4 days of
incubation at 37uC to determine colony-forming units (CFU) per
respiratory tract. A minimum of 3 mice per group was used. A two-
tailed t test was used for statistical analysis.
Bronchoalveolar Lavage (BAL)
Mice were euthanized by carbon dioxide inhalation and
dissection was performed to expose the trachea and lungs. A 20-
gauge blunt-ended needle was inserted into a small incision
towards the top of the trachea and tied in place with surgical
thread. BAL was performed by flushing the lungs two times with
0.7 ml of sterile PBS. Aliquots of BAL fluid were used for cell
counting on a hemocytometer and for cytospin centrifugation.
Cytospin centrifugation was performed at 600 rpm for 5 minutes
and the slides were stained with modified Wright’s stain (Hema 3H
Stain Set, Fisher) according to the manufacturer’s protocol to
identify different cell types. Approximately 100 cells from several
microscope fields (5–6) were counted and identified for each
sample.
Lung Perfusion and Cell Preparation
Mice were euthanized by carbon dioxide inhalation and the
thoracic cavity was exposed. The aorta was nicked to allow blood
to drain and 10 ml of PBS was injected into the right ventricle of
the heart, resulting in the removal of blood from the lung tissue.
The lung tissue was finely cut with scissors and treated with
collagenase type 4/DNAse I for 45 min at 37uC. The digested
tissue was passed through a cell strainer (BD Falcon) using the
plunger from a 20 ml syringe and the cells were resuspended in
sterile PBS.
RNA Preparation from Lung Tissue
Mice were euthanized by carbon dioxide inhalation and the
thoracic cavity was exposed. The two left lobes of the lung were
removed, snap frozen in a dry ice/ethanol bath and stored at
280uC until further use. RNA preparation from whole lung tissue
was performed using the phenol-chloroform method. Samples
were homogenized in 1 ml of RNA Stat-60
TM (Tel-Test, Inc.),
200 ml of chloroform was added and the samples were centrifuged
at 13,0006g for 15 minutes at 4uC. The aqueous phase was
transferred to a 1.5 ml tube containing 500 ml of isopropanol and
the samples were stored at 220uC overnight. The samples were
centrifuged at 13,0006g for 15 minutes at 4uC and the RNA
pellets were washed twice with 80% ethanol and dried in a DNA
Speedvac (Savant) at low temperature for 15 min until the pellet
became transparent. The pellet was resuspended in 50 mlo f
nuclease-free H2O and placed in a 65uC water bath for 30 min.
Samples were placed on ice and quantification of RNA was
performed using a ND-1000 NanoDrop spectrophotometer at
260 nm. Measurements of A260/280 were used to determine the
purity of the RNA.
cDNA Synthesis
The synthesis of cDNA was performed with a Reverse
Transcription System kit (Promega) according to the manufactur-
er’s protocol using random primers. One mg of RNA was used for
each sample. The reaction was incubated at room temperature for
10 min and reverse transcription was performed in a thermal
cycler at 42uC for 15 min and 95uC for 5 min. Samples were
placed on ice for 5 min to stop the reaction and diluted 1:10 in
nuclease-free H2O.
Real-Time PCR
Real-Time PCR was performed using the SYBR green system
(ABI). Primers were generously provided by Dr. Stefanie Vogel
(UMB) or designed using Primer Express Software. Primers used
were: HPRT forward primer 59-GCTGACCTGCTGGATTA-
CATTAA-39; HPRT reverse primer 59-TGATCATTACAGTAG-
CTCTTCAGTCTGA-39; KC forward primer 59-GCTTGAAG-
GTGTTGCCCTCA-39; KC reverse primer 59-GTGGCTATGA-
CTTCGGTTTGG-39; LIX forward primer 59-AGCTGCCCC-
TTCCTCAGTC-39; LIX reverse primer 59-TCCACCTCCAAAT-
TAGCGATCAAT-39; MIP-2 forward primer 59-ACCAACCAC-
CAGGCTACAGG-39; MIP-2 reverse primer 59-CAGGCATTGA-
CAGCGCAGT-39; IL-17 forward primer 59-ACCTCAACCGT-
TCCACGTCA-39; IL-17 reverse primer 59-CAGGGTCTTCA-
TTGCGGTG-39; IL-6 forward primer 59-TGTCTATACCACTT-
CACAAGTCGGAG-39;I L - 6r e v e r s ep r i m e r5 9-GCACAAC-
TCTTTTCTCATTTCCAC-39;T N F - a forward primer 59-GAC-
CCTCACACTCAGATCATCTTCT-39;TNF-a reverse primer 59-
CCACTTGGTGGTTTGCTACGA-39;I F N - c forward primer 59-
CTGCCACGGCACAGTCATTG-39;I F N - c reverse primer 59-
TGCATCCTTTTTCGCCTTGC-39.Am a s t e rm i xs o l u t i o nw a s
prepared asfollows: 12.5 mlof2XSYBRgreenmastermix,0.75 mlof
the appropriate forward and reverse primers (stock concentration:
10 mM) and 6 mlo fH 2Opersample.Five ml(a p p r o xi m a t e l y3 0n g )o f
cDNA and 20 ml of the master mix solution were added to each well
of a 96 well optical reaction plate (Applied Biosystems). All samples,
including a H2O control, were run in duplicates. The data were
analyzed using DDCt calculations and expression of all genes was
normalized against the mouse housekeeping gene, HPRT. Results
were expressed as fold increase over values from PBS-treated mice.
Cytokine ELISAs
Mice were euthanized by carbon dioxide inhalation and the
thoracic cavity was exposed. The two left lobes of the lung were
removed and homogenized in 1.5 ml of Tris-HCl (pH 7.4)
containing 1 mg of pepstatin (Roche) and 1 Complete Mini
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The samples were centrifuged at 13,0006g for 5 min and the
supernatants were transferred to 1.5 ml eppendorf tubes. This
process was repeated two times to remove residual cells. The
supernatants were stored at 280uC and ELISA was performed at
the UMB Cytokine Core Laboratory.
Flow Cytometry Analysis
Lung and BAL cells were harvested and prepared as described
above. Cells were then surfaced stained with specific antibodies
(eBiosciences) for CD11b (Clone M1/70), CD11c (Clone N418),
Gr-1 (Clone RB6-8C5), and CD3 (Clone 145-2C11), for 30 min at
4uC, and then washed in staining buffer (2% FBS in PBS). Cells
were processed for intracellular staining using Intracellular
Staining buffers (eBiosciences) per the manufacturer’s instructions
and were stained with either an antibody to IL-17 (eBiosciences,
Clone eBio17B7) or an isotype control antibody (eBiosciences).
Events were collected on a LSRII flow cytometer (Becton
Dickinson) driven by FACSDiva software (Becton Dickinson),
and analyzed using FlowJo software (Tree Star).
Intranasal Administration of a-IL-17
Neutralization of IL-17 was performed by intranasal inoculation
of 100 mg (in 50 ml PBS) of a rat monoclonal a-IL-17 antibody
(R&D Systems). Purified rat IgG (Sigma) was used as a control.
Statistical Analysis
All statistical analysis was performed using SigmaStat (Systat
Software Inc.). Statistical comparisons in gene expression and
ELISA experiments were performed using a One-Way ANOVA
assay allowing for comparison of three sets of data per time point.
A Tukey post-hoc test was used for pairwise comparison of data
sets.
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